In a world of swirling news stories, voices vying for attention, and misinformation around every corner, patients need someone to cut through the noise. For many, that voice is the pharmacist.

The role of community pharmacy is constantly evolving. Now more than ever, pharmacists are searching for new ways to drive revenue and, most importantly, improve patient care.We sat down with Brittany Sanders, Co-Owner of The Pharmacy at Wellington in Little Rock, Arkansas, and winner of the 2025 NCPA Willard B. Simmons Independent Pharmacist of the Year Award, to get her insights around: Overcoming the current challenges facing independent pharmacies today, strategies for driving new streams of revenue, and becoming a valuable resource that the community trusts for high quality patient care.

The era when pharmacy owners could rely on generous contracts and healthy margins is no longer. With rising costs, minimum to negative reimbursement rates, and PBM battles raging on, pharmacy closures have continued accelerating.

Today’s patient has access to an unmanageable amount of information. With thousands of differing narratives, patients are overwhelmed with information and a lack of support in determining what’s factually sound, and what makes sense for their individual care journey. With medical misinformation on the rise, it’s critical that patients receive personalized care messages through the right channel, at the right time.

Five years ago, RedSail Technologies was born from a bold vision: to empower pharmacies with the technological tools, support, and innovation they need to thrive. Today, we celebrate not just our anniversary, but the journey that’s brought us here—and the people who’ve made it possible.

Meet a current pharmacy student, a former professor, and hear how the industry is changing and pushing forward.

H.R.1, also known as The One Big Beautiful Bill Act (OBBA), is a big deal. It’s packed with sweeping changes that touch nearly every corner of federal policy. But for independent pharmacies, the most immediate and personal impact is clear: it’s about your patients.

Every year, pharma loses an estimated $630B on patient non-adherence—but the problem with adherence may not be the message itself, but where the message lands. Pharma invests billions annually in patient outreach: $10B in traditional advertisements, $20B on provider marketing, and an average $21M per drug on promotional efforts aimed at helping patients start and stay on therapy.

Connect 2025 is in the books, and we’re still buzzing about it. Earlier this month, we brought the RedSail Technologies network to Grapevine, TX and proved that everything really is bigger in Texas.